IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 199 filers reported holding IMPAX LABORATORIES INC in Q3 2016. The put-call ratio across all filers is 1,411.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $3,000 | -25.0% | 203 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $4,000 | +33.3% | 203 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $3,000 | +50.0% | 203 | +22.3% | 0.00% | 0.0% |
| Q4 2016 | $2,000 | -66.7% | 166 | -33.3% | 0.00% | -66.7% |
| Q3 2016 | $6,000 | 0.0% | 249 | +20.9% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | +20.0% | 206 | +19.8% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 172 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $7,000 | +16.7% | 172 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | -25.0% | 172 | 0.0% | 0.00% | -20.0% |
| Q2 2015 | $8,000 | 0.0% | 172 | -3.9% | 0.01% | 0.0% |
| Q1 2015 | $8,000 | +60.0% | 179 | +4.1% | 0.01% | +66.7% |
| Q4 2014 | $5,000 | 0.0% | 172 | -15.3% | 0.00% | -25.0% |
| Q3 2014 | $5,000 | 0.0% | 203 | +11.5% | 0.00% | +33.3% |
| Q2 2014 | $5,000 | 0.0% | 182 | 0.0% | 0.00% | -25.0% |
| Q1 2014 | $5,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $98,362,000 | 8.33% |
| Krensavage Asset Management, LLC | 587,882 | $18,824,000 | 6.75% |
| Hound Partners | 6,757,558 | $216,377,000 | 5.88% |
| Asymmetry Capital Management, L.P. | 62,050 | $1,987,000 | 5.18% |
| Orbimed Advisors | 6,776,100 | $216,971,000 | 2.28% |
| Pennant Capital Management, LLC | 2,083,074 | $66,700,000 | 1.90% |
| UNIVERSITY OF NOTRE DAME DU LAC | 41,104 | $1,316,000 | 1.62% |
| Tygh Capital Management, Inc. | 137,975 | $4,418,000 | 1.29% |
| JW Asset Management, LLC | 53,373 | $1,709,000 | 1.12% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,784 | $8,863,000 | 0.93% |